Skip to content

EV / sales at other companies

Insulet logo
InsuletPODD
5.3×-3.4×
Medtronic logo
MedtronicMDT
3.6×-0.4×
AdaptHealth logo
AdaptHealthAHCO
1.1×0.0×
Mannkind logo
MannkindMNKD
-3.0×
Abbott logo
AbbottABT
4.6×-1.0×
Omnicell logo
OmnicellOMCL
-0.1×

Other financials

Income statement

See full
Revenue$247.2M+5.5%
Gross profit$136.8M+15.5%
Operating income-$17.4M+85.6%
Net income-$20.4M+84.4%
EPS (diluted)-$0.30+84.8%

Balance sheet

See full
Cash & equivalents$179.3M+235%
Total debt$734.7M+49.0%
Total equity$132.4M-14.7%
Total assets$1.2B+25.1%

Cash flow

See full
Operating cash flow$11.1M+160%
CapEx$6.3M+111%
Free cash flow$4.8M+123%

Valuation

See full
Market cap$1.03B-23.6%
Enterprise value$1.58B-11.3%
P/S-0.4×

Profitability

See full
Gross margin54.9%+2.7pp
Operating margin-8.2%-2.9pp
Net margin-9.2%-3.1pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-65.7%-14.7pp
Debt / equity5.5×+2.4×
Current ratio3.6×+1.3×

Where this comes from

Calculated from Tandem Diabetes Care’s reported figures.

Based on the most recent quarter.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tandem Diabetes Care's EV / sales?
Tandem Diabetes Care (TNDM) reported EV / sales of 1.8× in Q1 2026.
How has Tandem Diabetes Care's EV / sales changed year-over-year?
Tandem Diabetes Care's EV / sales increased by 4.1% year-over-year, from 1.7× to 1.8×.
What is the long-term trend for Tandem Diabetes Care's EV / sales?
Over 5 years (2020 to 2025), Tandem Diabetes Care's EV / sales has grown at a -31.5% compound annual growth rate (CAGR), from 12× to 1.8×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.